Lactifer Oral Suspension 200ml

Lactifer Oral Suspension 200ml is prescribed for adults with CIC (bowel dysfunction with no definite underlying cause) when dietary measures and routine over-the-counter options fail to provide relief and for patients with cirrhosis who have or are at risk of overt hepatic encephalopathy (HE). Chemically similar to lactulose, Lactifer Oral Suspension 200ml has a more predictable cathartic effect, a less sweet taste, and is typically better tolerated, with fewer reports of nausea, bloating, and excessive gas. Because it is minimally absorbed from the gastrointestinal tract, systemic exposure is negligible.

In constipation, Lactifer Oral Suspension 200ml increases stool water content and bowel transit without the cramping. In hepatic encephalopathy, Lactifer Oral Suspension 200ml is fermented in the colon, which lowers the local pH. This converts ammonia into a charged form (ammonium) that cannot be absorbed. This shifts the gut bacteria away from ammonia-producing species, reducing the amount of ammonia reaching the brain.

Chronic idiopathic constipation (CIC) in adults

Primary or adjunct therapy when lifestyle and dietary measures are insufficient.

Hepatic encephalopathy

Treatment and secondary prevention of HE in patients with cirrhosis, a better alternative to lactulose.

Functional constipation

Short-term use in adults, including those intolerant to other osmotic laxatives.

Bowel regularity

Used where gentler, long-term osmotic laxation is preferred over stimulant laxatives.

• Gentle osmotic laxation without the urgency, cramping, or electrolyte shifts of stimulant laxatives.

• Minimally absorbed, so systemic side effects are limited.

• Generally better tolerated than lactulose, with a lower likelihood of bloating, flatulence, and nausea.

• Effective in hepatic encephalopathy by lowering colonic pH, trapping ammonia, and modulating gut microbiota.

• Can be mixed with water, juice, tea, coffee, or soda, improving adherence.

Common

• Gas (flatulence)

• Bloating, distension (expansion of the abdominal cavity), or cramping

• Diarrhoea (at higher doses)

• Upper respiratory tract infection

Uncommon

• Nausea

• Increased creatine phosphokinase (CPK)

• Mild headache

Serious side effects requiring immediate attention

• Dehydration and electrolyte disturbances

• Hypokalaemia (low potassium levels)

• Hyponatraemia (low sodium levels)

• Allergic reactions, which may present as rash, itching, swelling of the face, lips, or throat

• Severe abdominal pain, vomiting, or signs of bowel obstruction

Empty the prescribed dose of powder into a glass. Add 120 to 240 mL of water, juice, or another common beverage, stir until fully dissolved, and drink the entire contents. Take once daily, preferably with a meal. Drink adequate water throughout the day to avoid dehydration. Take other oral medications at least 2 hours before or after Lactifer Oral Suspension 200ml, as it may reduce their absorption. Do not stop Lactifer Oral Suspension 200ml abruptly in patients being treated for hepatic encephalopathy without medical advice, as this may precipitate a relapse.

Lactifer Oral Suspension 200ml acts in the colon through two complementary mechanisms: an osmotic laxative effect and a pH-lowering, ammonia-trapping effect.

The small intestine lacks the enzymes needed to break down Lactifer Oral Suspension 200ml, so it passes unchanged into the colon, where it acts as an osmotically active solute. Because lacitol cannot be absorbed, it stays in the colon and creates a high concentration of dissolved particles inside the bowel. Water moves from the body tissues across the colonic wall into the bowel to balance this concentration, increasing stool water content, softening the stool, and distending the colon. This distension stimulates peristalsis (movement of the muscles throughout the digestive tract) and promotes bowel movements.

Once in the colon, lacitol is fermented by resident bacteria into SCFAs such as lactic, acetic, and propionic acid, which lower colonic pH. At a lower pH, ammonia (lipid-soluble and readily absorbed across the gut wall) becomes protonated to ammonium (NH4+), which is charged and cannot cross cell membranes. Ammonium is therefore trapped in the colon and excreted in stool instead of entering portal circulation.

The acidic, carbohydrate-rich environment also favours saccharolytic bacteria (which produce little ammonia), further reducing gut-derived ammonia. In patients with cirrhosis, where the liver can no longer clear ammonia efficiently, this reduction reduces the risk of hepatic encephalopathy.

• High-fibre/high-volume meals (MILD): May increase gas and bloating.

• Alcohol (MODERATE): Worsens dehydration from laxative-induced fluid loss and may result in hepatic encephalopathy in cirrhotic patients. Limit or avoid.

• Other oral medicines (MODERATE): Can reduce absorption of co-administered oral drugs. Space by at least 2 hours.

Oral medications (thyroxine, oral contraceptives, antiepileptics)

MODERATE

May reduce absorption of concomitant oral drugs. Space by at least 2 hours.

Other laxatives (lactulose, polyethylene glycol, senna)

MODERATE

Additive laxative effect increases risk of diarrhoea, dehydration, and electrolyte loss.

Diuretics (furosemide, hydrochlorothiazide)

MODERATE

Increased risk of dehydration and electrolyte imbalance, especially hypokalaemia.

Digoxin

CAUTION

Diarrhoea-induced hypokalaemia increases the risk of digoxin toxicity.

Corticosteroids

CAUTION

Higher risk of hypokalaemia with prolonged therapy.

• Galactosaemia: Contraindicated due to galactose content, which cannot be metabolised and can cause severe toxicity.

• Bowel obstruction: Contraindicated in confirmed or at-risk cases of mechanical bowel obstruction.

• Severe inflammatory bowel disease: Use with caution, especially in people with obstruction, toxic megacolon, or fulminant colitis.

• Chronic diarrhoea: Avoid, as Lactifer Oral Suspension 200ml will worsen stool frequency and fluid loss.

• Severe renal impairment: Use with caution and monitor electrolytes if severe diarrhoea occurs.

• Severe cardiovascular disease: Use with caution due to the risk of electrolyte disturbances.

Overdose typically presents as severe diarrhoea, abdominal cramping, dehydration, and electrolyte disturbances. In patients with cirrhosis, excessive diarrhoea can precipitate hypovolaemia (low blood volume) and worsen hepatic encephalopathy. Management includes discontinuing the medication, rehydrating orally or intravenously, correcting electrolyte abnormalities, and monitoring renal function. Seek immediate medical help if you experience severe diarrhoea, confusion, or weakness.

For constipation, if you forget a dose, take it as soon as you remember that day. If it is close to the next dose, skip the missed dose and continue your regular schedule. Do not double-dose, as this can cause excessive diarrhoea and dehydration. In hepatic encephalopathy, consistent dosing is critical. If you miss more than one dose, contact your doctor promptly, as interruption may result in a relapse.